Open AccessLong-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma
Author(s) -
Miyuki Taniguchi,
Soo Ryang Kim,
Susumu Imoto,
Hirotsugu Ikawa,
Kenji Ando,
Keiji Mita,
Shuichi Fuki,
Noriko Sasase,
Toshifumi Matsuoka,
Masatoshi Kudo,
Yoshitake Hayashi
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.1997
Subject(s) - hepatocellular carcinoma , percutaneous ethanol injection , medicine , gastroenterology , liver function , percutaneous , radiofrequency ablation , survival rate , hepatitis b virus , hepatitis c virus , hepatitis b , surgery , virus , ablation , immunology
To evaluate long-term follow-up of minimum-sized hepatocellular carcinoma (HCC) treated with percutaneous ethanol injection (PEI).